Commentary
Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance
2020 Volume 14 Issue 2 Pages 103-104
Details
2020 Volume 14 Issue 2 Pages 103-104
Drug quantity purchase in China has reshaped the pattern of drug market with lower price of generic drugs and relatively higher price of original brand-name drugs. However, most Chinese people do not trust the safety and efficacy of the generic drugs that sold at a very low price. Ultra-low price of generic agents may weaken patients' drug recognition and compliance, and affect the implementation of drug quantity purchase policy.
